High-density lipoprotein metabolism and endothelial function

Current Opinion in Endocrinology, Diabetes, and Obesity
Charles J Lowenstein, Scott J Cameron

Abstract

High-density lipoprotein (HDL) protects against atherosclerosis, transporting cholesterol from peripheral cells to the liver, where it is excreted into the bile. However, HDL also has prominent vascular protective effects. Recent studies have uncovered mechanisms through which HDL decreases vascular inflammation, boosts nitric oxide production, and inhibits thrombosis. The discovery that dysfunctional HDL can also have proinflammatory effects has uncovered a new aspect of HDL biology. Low-density lipoprotein is the primary target for drug therapy of dyslipidemias. Drugs that increase HDL also affect additional metabolic pathways. Development of selective drugs targeting key aspects of HDL metabolism may enable us to alter the composition of HDL and inhibit atherogenesis.

References

Feb 5, 1976·The New England Journal of Medicine·G G RhoadsA Kagan
Feb 1, 1990·Prostaglandins, Leukotrienes, and Essential Fatty Acids·J D Symons
Nov 1, 1995·Arteriosclerosis, Thrombosis, and Vascular Biology·G W CockerillP J Barter
Sep 22, 1998·Arteriosclerosis, Thrombosis, and Vascular Biology·D T AshbyP J Barter
Jan 23, 1999·The Journal of Clinical Investigation·J H GriffinJ A Fernández
Apr 9, 1999·Arteriosclerosis, Thrombosis, and Vascular Biology·G W CockerillD O Haskard
Jul 7, 1999·The Journal of Clinical Investigation·H M DanskyJ L Breslow
Oct 27, 1999·Proceedings of the National Academy of Sciences of the United States of America·J IgarashiT Michel
Dec 2, 2000·Science·K Simons, E Ikonen
Dec 14, 2002·The International Journal of Biochemistry & Cell Biology·Sung-Hee ParkYoung-Hee Kang
Feb 6, 2003·The Journal of Clinical Investigation·Tatsuro IshidaThomas Quertermous
Feb 6, 2003·The Journal of Clinical Investigation·Weijun JinDaniel J Rader
May 17, 2003·The Journal of Clinical Investigation·Ming GongEric J Smart
Oct 16, 2004·Circulation Research·Philip J BarterAlan M Fogelman
Mar 2, 2005·Nature Reviews. Drug Discovery·Patrick Linsel-Nitschke, Alan R Tall
Aug 16, 2005·Trends in Cardiovascular Medicine·Mohamad NavabAlan M Fogelman
Mar 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Anatol Kontush, M John Chapman
Jun 10, 2006·Circulation Research·Chieko MineoPhilip W Shaul
Mar 3, 2007·The Journal of Clinical Investigation·Tomas VaisarJay W Heinecke
Mar 21, 2007·Circulation·Sabine EichingerJohn H Griffin
Aug 25, 2007·Nature Reviews. Immunology·Klaus LeySussan Nourshargh
Sep 29, 2007·Atherosclerosis·J A TroughtonUNKNOWN PRIME Study Group
Nov 7, 2007·The New England Journal of Medicine·Philip J BarterUNKNOWN ILLUMINATE Investigators
Mar 20, 2008·JAMA : the Journal of the American Medical Association·Tamali BhattacharyyaStanley L Hazen
Sep 4, 2009·The Journal of Biological Chemistry·Arundhati UndurtiStanley L Hazen

❮ Previous
Next ❯

Citations

Aug 10, 1981·Clinica Chimica Acta; International Journal of Clinical Chemistry·J EyreN E Miller
Mar 26, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·S R KhanV Wynn
Jun 16, 1982·Clinica Chimica Acta; International Journal of Clinical Chemistry·M S JauhiainenE V Puhakainen
Nov 30, 1984·Clinica Chimica Acta; International Journal of Clinical Chemistry·J R MarsdenS Shuster
Jan 4, 2001·The Journal of Nutritional Biochemistry·H OdaA Yoshida
Apr 16, 2011·Dementia and Geriatric Cognitive Disorders·Mitzi M GonzalesAndreana P Haley
Dec 3, 2014·Journal of Proteomics·Francesco FinamoreJean-Charles Sanchez
Dec 15, 2010·Expert Review of Proteomics·Susan YuditskayaGregory J Kato

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.